A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis | Zendy

Teerapong Monmaturapoj | Zendy; Preecha Montakantikul | Zendy; Piroon Mootsikapun | Zendy; Pramote Tragulpiankit | Zendy

Open Access

A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis

Author(s) -

Teerapong Monmaturapoj,

Preecha Montakantikul,

Piroon Mootsikapun,

Pramote Tragulpiankit

Publication year - 2012

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2012.07.009

Subject(s) - medicine , ceftriaxone , placebo , randomized controlled trial , group b , adverse effect , prospective cohort study , antibiotics , gastroenterology , surgery , alternative medicine , pathology , microbiology and biotechnology , biology

To compare the clinical and bacteriological effectiveness of intravenous (IV) ceftriaxone followed by oral cefditoren pivoxil or IV ceftriaxone for acute pyelonephritis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research